Your browser doesn't support javascript.
loading
Group acceptance and commitment therapy (ACT) for bipolar disorder and co-existing anxiety - an open pilot study.
Pankowski, Sara; Adler, Mats; Andersson, Gerhard; Lindefors, Nils; Svanborg, Cecilia.
Afiliação
  • Pankowski S; a Department of Clinical Neuroscience , Karolinska Institutet , Stockholm , Sweden .
  • Adler M; a Department of Clinical Neuroscience , Karolinska Institutet , Stockholm , Sweden .
  • Andersson G; a Department of Clinical Neuroscience , Karolinska Institutet , Stockholm , Sweden .
  • Lindefors N; b Department of Behavioural Sciences and Learning , Linköping University , Linköping , Sweden.
  • Svanborg C; a Department of Clinical Neuroscience , Karolinska Institutet , Stockholm , Sweden .
Cogn Behav Ther ; 46(2): 114-128, 2017 03.
Article em En | MEDLINE | ID: mdl-27647353
ABSTRACT
Previous studies have supported acceptance and commitment therapy (ACT) for reducing impairment related to various chronic conditions. ACT may possibly be beneficial for bipolar disorder (BD) with co-existing anxiety, which is associated with a poorer treatment outcome. Efforts are needed to identify suitable psychological interventions for BD and co-existing anxiety. In this open clinical trial, we included 26 patients with BD type 1 or 2 at an outpatient psychiatric unit specializing in affective disorders. The intervention consisted of a 12-session manualized group treatment that included psychoeducation, mindfulness, engaging in values-based behaviour, cognitive defusion, acceptance and relapse prevention modules. Participants completed four self-report questionnaires covering anxiety symptoms (Beck Anxiety Inventory - BAI), depressive symptoms (Beck Depression Inventory - BDI-II), quality of life (Quality of Life Inventory - QOLI) and psychological flexibility (Acceptance and Action Questionnaire - AAQ-2) before, during and after the treatment. At post-treatment, the participants reported significant improvements in all outcome measures, with large effects (Cohen's d between 0.73 and 1.98). The mean reduction in anxiety symptoms was 45%. At post-treatment, 96% of the patients were classified as responders on at least one of the outcome measures. A limitation is that the trial is uncontrolled. The results suggest that ACT has the potential to be an effective treatment for BD patients with co-existing anxiety. Further randomized studies are warranted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Psicoterapia de Grupo / Transtorno Bipolar / Avaliação de Resultados em Cuidados de Saúde / Terapia de Aceitação e Compromisso Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ansiedade / Psicoterapia de Grupo / Transtorno Bipolar / Avaliação de Resultados em Cuidados de Saúde / Terapia de Aceitação e Compromisso Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article